Back

Incidence and progression of left ventricular involvement in patients with arrythmogenic cardiomyopathy

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease 1 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Arancha Diaz Exposito

Virgin of Victory University Hospital, Malaga (Spain)

5 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors in wild-type transthyretin amyloid cardiomyopathy: what to expect?
Doctor L. Pinheiro (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Therapeutic value of spironolactone in wild-type transthyretin amyloid cardiomyopathy
Doctor L. Pinheiro (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Stabilizers of transthyretin in amyloid cardiomyopathy: a systematic review and meta-analysis.
Ms L. Burgos (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Improving survival rates of patients with light-chain cardiac amyloidosis in recent years
Doctor T. Nabeta (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Left ventricular non compaction in sub-saharan african adults
Doctor N. GAYE (Dakar, SN)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Phenotypic manifestation based on genetics and prevalence of secondary mutations in a sample of patients diagnosed with arrhythmogenic cardiomyopathy
thumbnail
Congress Presentation
Overlap in scarring phenotypes between non-dilated left ventricular cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: Implications for prognostic stratification
thumbnail
Congress Presentation
Exercise and phenotypic progression in arrhythmogenic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources